Nalaganje...
Tumor necrosis factor-mediated disposition of infliximab in ulcerative colitis patients
Ulcerative Colitis (UC) is an inflammatory bowel disease typically affecting the colon. Patients with active UC have elevated tumor necrosis factor (TNF) concentrations in serum and colonic tissue. Infliximab is a monoclonal antibody directed against TNF and binds with high affinity. Target-mediated...
Shranjeno v:
| izdano v: | J Pharmacokinet Pharmacodyn |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer US
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6868113/ https://ncbi.nlm.nih.gov/pubmed/31489538 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10928-019-09652-5 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|